Evolution of a chemosensitive core-binding factor AML into an aggressive leukemia with eosinophilic differentiation

Core-binding factor AML can evolve from good-risk disease into aggressive disease through the gain of additional genomic aberrations. In this unique case, an AML patient died of hypereosinophilic syndrome with solid organ infiltration of differentiated eosinophils.

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Xiao, Wenbin, Yabe, Mariko, Offin, Michael, Khattar, Pallavi, Baik, Jeeyeon, Daley, Ryan J., Pappacena, Jeremy J., Roshal, Mikhail, Zhang, Yanming, Tallman, Martin S., Cai, Sheng F.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Exceptional Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6039660/
https://ncbi.nlm.nih.gov/pubmed/29950292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018016675
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars